TELA TELA Bio, Inc.: institutional ownership and insider trading
46 funds reported holding $21.5M of TELA Bio, Inc. in their latest 13F filings; in Q2 2026 funds net sold $1.41M, with 10 new positions and 1 funds selling out; over the last 12 months insiders bought $4.19M and sold $0 on the open market; over its last four quarters it reported revenue of $79.9M and net income of −$41.1M.
TELA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $19.3M, net income −$11.3M, EPS -0.20
- Quarter ended Mar 31, 2026: revenue $19.1M, net income −$12.3M, EPS -0.21
- Quarter ended Dec 31, 2025: revenue $20.9M, net income −$9.01M, EPS -0.17
- Quarter ended Sep 30, 2025: revenue $20.7M, net income −$8.60M, EPS -0.19
Famous investors holding TELA
- Renaissance Technologies (Renaissance Technologies): $43.6K, 0.0% of the portfolio
Largest institutional holders of TELA
- Essex Woodlands Management, Inc. — $5.79M
- Nantahala Capital Management, LLC — $4.42M
- VANGUARD GROUP INC — $2.16M
- Stonepine Capital Management, LLC — $2.00M
- SILVERARC CAPITAL MANAGEMENT, LLC — $1.60M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.18M
- DAFNA Capital Management LLC — $1.08M
- PERKINS CAPITAL MANAGEMENT INC — $1.03M
- Sio Capital Management, LLC — $477K
- WealthTrust Axiom LLC — $343K
Recent TELA insider trades
- Sep 17, 2026: Capper Joseph H bought 75,000 shares ($89.0K)
- Sep 15, 2026: Capper Joseph H bought 75,000 shares ($78.5K)
- Aug 17, 2026: Getz Heather C bought 12,500 shares ($8.25K)
- Aug 14, 2026: Getz Heather C bought 15,000 shares ($10.5K)
5%+ owners
- EW Healthcare Partners Fund 2-GP, L.P.: 17.2% (Schedule 13D, filed Jun 9, 2026)
- Nantahala Capital Management, LLC: 12.9% (Schedule 13G/A, filed Aug 14, 2026)
- Lytton, Laurence W.: 5.5% (Schedule 13G/A, filed May 15, 2026)
Who owns the most TELA stock?
The largest institutional holders of TELA Bio, Inc. in the latest 13F filings are Essex Woodlands Management, Inc. ($5.79M), Nantahala Capital Management, LLC ($4.42M), VANGUARD GROUP INC ($2.16M).
Are insiders buying or selling TELA?
Over the last 12 months insiders bought $4.19M and sold $0 of TELA Bio, Inc. stock on the open market (SEC Form 4).
Which famous investors own TELA?
Renaissance Technologies.
What was TELA's revenue last quarter?
TELA Bio, Inc. reported revenue of $19.3M for the quarter ended June 30, 2026, with net income of −$11.3M.
Which ETFs hold TELA?
2 ETFs and mutual funds hold it among their top 100 positions, including JSCGX, JMCGX.